SUVICA INC

Medtech · Private

High-throughput screening (HTS) system for clonogenic assays to measure single-cell proliferation and tumor regrowth

suvica.com →
Grants
$298K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
$4.0M
4 awards · Health and Human S
#141 of 4531 in medtech
Patents
3
2 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · Igf::ot::igf Radiation Modulators For Head And Neck Cancer.$249,672
Federal contractDepartment of Health and Human Services · Igf::ot::igf Contract Title: Radiation Modulators For Head And Neck Cancer Pop: 9/16/15 - 3/15/17$1,498,852
Federal contractDepartment of Health and Human Services · Igf::ot::igf Clonogenic High-throughput Asssay For Screening Radiation Modulators$297,604
Federal contractDepartment of Health and Human Services · Topic #366 - Phase II SBIR Contract - Clonogenic High - Throughput Assay For Screening Radiation Modulation$1,999,989
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
138SILK TECHNOLOGIES, LTD.$4.1M$5.0M
139Neurable Inc.$4.1M$12M
140DXDISCOVERY INC$4.1M—
141SUVICA INC$4.0M—
142IMMUNETICS, INC.$4.0M$1.5M
143SWITCHBOX INC$4.0M—
144Springactive, Inc.$3.8M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 3

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.